CARMEN DUNCAN: Open Payments
NPI 1659154011 · VALDOSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,906 in 89 payments from 20 companies in 2025. Trend: 2023 $407 · 2024 $1,692 · 2025 $1,906
Food & beverage: $1,802Education: $104
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $557 |
| Janssen Biotech, Inc. | 10 | $294 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $179 |
| Ardelyx, Inc. | 9 | $165 |
| Phathom Pharmaceuticals, Inc. | 10 | $115 |
| GENZYME CORPORATION | 3 | $105 |
| QOL Medical, LLC | 3 | $91 |
| PFIZER INC. | 3 | $63 |
| Braintree Laboratories, Inc. | 2 | $62 |
| Gilead Sciences, Inc. | 2 | $49 |
Products named: TREMFYA, LINZESS, XIFAXAN, IBSRELA, SKYRIZI, RINVOQ, DUPIXENT, VOQUEZNA.
Industry payments across GA — which companies pay providers there.
